Registry for Hypoparathyroidism Wuerzburg
NCT05585593 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2022-11-08
Summary
Long-term conventional treatment of chronic hypoparathyroidism does not fully restore calcium homeostasis leading to increased morbidity, emergency events and reduced subjective health status. To further investigate general morbidity, hypocalcemic events, subjective and daily life performance in patients with chronic hypoparathyroidism a standardized interview as well as blood sampling and examinations such as echocardiography and renal ultrasound are performed.
Conditions
- Comorbidities and Coexisting Conditions
- Morality
- Hypocalcemia
- Hypercalcemia
- Quality of Life
Sponsors & Collaborators
-
University of Wuerzburg
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-10-18
- Primary Completion
- 2032-01-01
- Completion
- 2032-01-01
Countries
- Germany
Study Locations
More Related Trials
-
Long-Term Therapy Outcomes When Treating Chronic Kidney Disease (CKD) Patients With Paricalcitol in German and Austrian Clinical Practice
NCT01083849 ·Status: COMPLETED
-
Impact of Parathyroidectomy on Vascular Calcification and Clinical Outcome in Hemodialysis Patients
NCT03724188 ·Status: COMPLETED
-
DePTH: De-emphasize PTH
NCT06288451 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Systematic Study of Parameters of Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD)
NCT02556216 ·Status: UNKNOWN
-
Regulation of Vitamin D Receptor (VDR),Calcium Sensing Receptor (CaSR), Cyclin D1,Ki67 and Proliferating Cell Nuclear Antigen (PCNA) in Primary Hyperparathyroidism
NCT01228786 ·Status: UNKNOWN
-
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
NCT00261950 ·Status: COMPLETED ·Phase: PHASE2
-
The Longitudinal PTH-Study
NCT03464149 ·Status: COMPLETED
-
Biomarkers and Event Patterns of Vascular Disease in Hemodialysis
NCT07170761 ·Status: ACTIVE_NOT_RECRUITING
-
Observational Study to Evaluate the Time to Achieving the Maintenance Dose of Zemplar® (Paricalcitol Injection) in the Treatment of Patients Suffering From End-stage Renal Disease and Severe Over-reactivity of the Parathyroid Glands
NCT01273597 ·Status: COMPLETED
-
Study to Evaluate the Effect of Intravenous (IV) Paricalcitol (Zemplar) on Cardiac Morbidity in Patients With Chronic Kidney Disease (CKD) Stage 5 Over 2 Years
NCT01073462 ·Status: COMPLETED
-
Mineral and Bone Disorders Outcomes in Stage 5D of Chronic Kidney Disease
NCT00995163 ·Status: COMPLETED
-
Study of the Influence of Dosages of 1-84 and 7-84 Fragments of Parathyroid Hormone Compared to Conventional Dosage on the Balance of Calcium and Phosphate in Hemodialysis (PTH)
NCT02859220 ·Status: COMPLETED ·Phase: NA
-
Treatment of Secondary Hyperparathyroidism in the Uremic Patient
NCT00469599 ·Status: TERMINATED ·Phase: NA
-
Cinacalcet to Treat Familial Primary Hyperparathyroidism
NCT00325104 ·Status: COMPLETED ·Phase: PHASE3
-
Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol
NCT01725113 ·Status: TERMINATED ·Phase: PHASE4
-
The Effects of Hemodialysis on Serum Sclerostin Levels
NCT03952819 ·Status: COMPLETED
-
Evaluation of Colecalciferol Substitution in Dialysis Patients
NCT00397475 ·Status: COMPLETED ·Phase: NA
-
Pyrophosphate Homeostasis and Hepatic Expression of ABCC6.Pyro-TH
NCT03576859 ·Status: COMPLETED ·Phase: NA
-
Evaluate Safety and Efficacy of Paricalcitol in Reducing Serum Intact Parathyroid Hormone in Chronic Kidney Disease
NCT01071070 ·Status: COMPLETED ·Phase: PHASE3
-
the Study on Prognostic for Hemodialysis Patients
NCT03194087 ·Status: UNKNOWN
-
Pharmacoepidemiological Study of Secondary Hyperparathyroidism in Lorraine
NCT02888639 ·Status: COMPLETED
-
The Study of Efficacy and Safety of REGPARA Drug in Dialysis Patients Have High Blood Levels of Parathyroid
NCT02056730 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy and Safety of Microwave Ablation for Mild-to-moderate Secondary Hyperparathyroidism Patients Undergoing Hemodialysis
NCT02332135 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Adherence to the Mediterranean Diet in Patients with Recurrent Renal Stones and Disease Osteometabolic
NCT06869603 ·Status: RECRUITING
-
A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism
NCT01149291 ·Status: COMPLETED